New study aims to discover whether insomnia treatment can reduce cardiovascular disease risks

It’s no secret that a good night’s rest can do wonders for one’s health, but those who struggle with insomnia have a nearly 50% increased risk of cardiovascular disease.

Why did Allogene cancel two clinical trials for its off-the-shelf cell therapy?

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we discuss

January 5, 2024

PPI Prevents Upper GI Bleeds During Intubation, With No Effect on Mortality

The common practice of using proton-pump inhibitors (PPIs) as prophylaxis against stress ulcers during invasive ventilation significantly reduced the risk of problematic gastrointestinal (GI) bleeds,

June 15, 2024

Why Andreessen Horowitz’s Vineeta Agarwala sees communication as the next opportunity for AI in healthcare

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) Vineeta Agarwala sees communication as an area

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.